645 related items for PubMed ID: 16048603
1. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[Abstract] [Full Text] [Related]
2. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J.
Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
[Abstract] [Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[Abstract] [Full Text] [Related]
4. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[Abstract] [Full Text] [Related]
5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
[Abstract] [Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Saudek F, Malaise J, Boucek P, Adamec M, Euro-SPK Study Group.
Nephrol Dial Transplant; 2005 May 15; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
[Abstract] [Full Text] [Related]
7. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
Pollock-Barziv SM, Dipchand AI, McCrindle BW, Nalli N, West LJ.
J Heart Lung Transplant; 2005 Feb 15; 24(2):190-4. PubMed ID: 15701436
[Abstract] [Full Text] [Related]
8. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
Nephrol Dial Transplant; 2005 May 15; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[Abstract] [Full Text] [Related]
9. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
Transplant Proc; 2005 Nov 15; 37(9):3738-42. PubMed ID: 16386523
[Abstract] [Full Text] [Related]
10. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Steurer W, Malaise J, Mark W, Koenigsrainer A, Margreiter R, Euro-SPK Study Group.
Nephrol Dial Transplant; 2005 May 15; 20 Suppl 2():ii54-62. PubMed ID: 15814551
[Abstract] [Full Text] [Related]
11. Outcome of renal transplants from pediatric donors <5 yr of age.
El-Sabrout R, Buch K.
Clin Transplant; 2005 Jun 15; 19(3):316-20. PubMed ID: 15877791
[Abstract] [Full Text] [Related]
12. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
Liver Transpl; 2003 Jun 15; 9(6):587-95. PubMed ID: 12783400
[Abstract] [Full Text] [Related]
13. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
Briggs D, Dudley C, Pattison J, Pfeffer P, Salmela K, Rowe P, Tydén G, European Tacrolimus Renal Rejection Study Group.
Transplantation; 2003 Jun 27; 75(12):2058-63. PubMed ID: 12829912
[Abstract] [Full Text] [Related]
14. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
Cheung CY, Chan HW, Liu YL, Chau KF, Li CS.
Nephrology (Carlton); 2009 Dec 27; 14(8):758-63. PubMed ID: 20025685
[Abstract] [Full Text] [Related]
15. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, Kamihira O, Kinukawa T, Ohshima S.
Clin Transplant; 2005 Apr 27; 19(2):153-7. PubMed ID: 15740548
[Abstract] [Full Text] [Related]
16. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
Liver Transpl; 2006 Oct 27; 12(10):1464-72. PubMed ID: 17004259
[Abstract] [Full Text] [Related]
17. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
Pediatr Transplant; 2006 Dec 27; 10(8):938-42. PubMed ID: 17096762
[Abstract] [Full Text] [Related]
18. Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
Cholongitas E, Shusang V, Germani G, Tsochatzis E, Raimondo ML, Marelli L, Senzolo M, Davidson BR, Patch D, Rolles K, Burroughs AK.
Clin Transplant; 2011 Dec 27; 25(4):614-24. PubMed ID: 20718824
[Abstract] [Full Text] [Related]
19. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
[Abstract] [Full Text] [Related]
20. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
Meier M, Nitschke M, Weidtmann B, Jabs WJ, Wong W, Suefke S, Steinhoff J, Fricke L.
Transplantation; 2006 Apr 15; 81(7):1035-40. PubMed ID: 16612281
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
